Navigation Links
Crdentia's VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
Date:9/11/2007

DALLAS, Sept. 11 /PRNewswire-FirstCall/ -- Crdentia Corp. (OTC Bulletin Board: CRDT), a leading healthcare staffing company, today announced that AudioStocks.com has posted an exclusive interview with Crdentia's Vice President of Marketing, Christina Hogan, on the Audiostocks.com website.

In the interview, Ms. Hogan discusses Crdentia's national marketing initiatives, brand positioning and plans for short-term and long-term strategic growth. In addition, the interview discusses market trends and how they favor the healthcare staffing industry.

The complete audio interview with Ms. Hogan can be found exclusively at http://www.audiostocks.com.

About Crdentia Corp.

Crdentia Corp., one of the nation's leading providers of healthcare staffing solutions, is focused on recruiting talented national and international healthcare professionals to meet the ever-increasing employment needs of over 1,500 clients. Crdentia is one of the few companies that can provide quality temporary staff for all healthcare industry positions including local nurses, travel nurses, allied health and locum tenens professionals. For more information, visit http://www.crdentia.com.

About AudioStocks.com

AudioStocks.com is an Internet-based publishing platform designed to create, catalogue, distribute and make functional, financial content and data related to that content. AudioStocks.com software is primarily used to: (1) facilitate executive and company participation in industry and event-based roundtables and conferences; (2) create and distribute audio-based content related to a particular private or public company or an industry in which a company conducts business; (3) append interview-related and other content to traditional press releases; and (4) for registered investment professionals only, to add interview-based audio content to financial res
'/>"/>

SOURCE Crdentia Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Christina Aguileras Silence Fuels Pregnancy Rumours
2. Protein provides antioxidant protection to Neurons
3. Acupuncture provides relief
4. Micro-camera provides new breast imaging technique
5. Hormone therapy provides no heart benefit
6. MicroRNA provides new insight into birth defects
7. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
8. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
9. Cholesterol provides immunity against infection by certain parasites
10. John Hopkins CGHH program provides Global Health education
11. London Hospital Provides Specialized Care For Pregnant Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...08 The January issue of European Urology , the o...logy published by Elsevier, will feature new recom...tly formulated by major scientific organizations. ...ted with advancing age and characterized by typica...levels. , Late-onset hypogonadism (LOH) is caus...
(Date:12/4/2008)...3, 2008) Stem cells derived from bone marrow may...isease called epidermolysis bullosa (EB), a disord... according to a study prepublished online in Blo... of Hematology. Epidermolysis bullosa is a diso... and blistering on touch, akin to third degree bu...
(Date:12/4/2008)...re-FirstCall/ -- Ramsey Partners, LLC, a specialty...to John Hancock Financial,Network (JHFN). Through...of,John Hancock Financial Network in Buffalo, NY,... consulting resources to the entire network nation..., "We are excited to be able to offer this ...
(Date:12/4/2008)...) In a statewide survey of medical professionals,...edical Research Institute at Harbor-UCLA Medical C...thern California Super Doctors, according to the D...fessional Media, Inc. conducted a survey of more t...08 list of Southern California Super Doctors for L...
Breaking Medicine News(10 mins):Health News:New recommendations by scientific societies about late-onset hypogonadism 2Health News:Bone marrow-derived stem cells may offer novel therapeutic option for skin disorder 2Health News:Bone marrow-derived stem cells may offer novel therapeutic option for skin disorder 3Health News:John Hancock Financial Network Offers Bank Owned Life Insurance Resource to Its Independent Career Firms Nationally 2Health News:John Hancock Financial Network Offers Bank Owned Life Insurance Resource to Its Independent Career Firms Nationally 3Health News:LA BioMed researchers among Southern California Super Doctors 2
...drug Vioxx has been in the news for the wrong reas...egarding Vioxx and the causative agent of the side...perty of the drug - the blood clotting mechanism, ...s known as COX-2 inhibitors are most often used to...
...ave implanted devices in their hearts face risks. ...arteries patent or open to allow an easy passage o... surgeons.Stents may be medicated or non medicated...ffer from internal blood clotting. The risk is fou...
...n Council of Medical Research, the data from Popul...ny significant increase in the age specific// inci.... As per received scheme of National Cancer Contr...is now being laid on early detection of Cancer by ...
...ut that, consumption of bacon and other processed ...ancer.// Dr Dominique S Michaud and other researc... have seen that people who consume more than 5 por...e to cancer affecting the bladder. The risk is inc...
Other Medicine News:Health News:Using Heart Stents Tends to Form More Clots 2
(Date:12/2/2008)...e/ -- Researchers using functional,MRI (fMRI) hav... brain,responsible for suppressing memory is dysf...ed psychiatric disorders. Results of the study wil... Radiological Society of North America,(RSNA). ,...er stress-related disorders,traumatic memories a...
(Date:12/2/2008)...Horizon Therapeutics, Inc., a,privately held biop...votal,Phase 3 trials evaluating its lead investig...ry endpoints. HZT-501, a novel, proprietary fixed-... famotidine, demonstrated a,statistically signifi...anti-inflammatory drug (NSAID)-induced upper gastr...
(Date:12/1/2008)...geGen has announced that an oral,presentation of ... clinical,trial of TG101348 in myeloproliferative...American Society of Hematology (ASH) Meeting. , ..., Title: A Phase I Study of TG1... JAK2-Selective Inhibitor, in Patients with, ...
(Date:12/1/2008)...licy , , ROCHESTER, Minn., Dec. 1 /PRNewsw...nds the use of the drug therapy etanercept ineffec...lammation of the liver caused by excessive consump...ished in the December issue of Gastroenterology ...EO ALERT: Additional audio and video resources, in...
Breaking Medicine Technology:Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Avantis Medical Systems Inc Announces Key Leadership Appointments 7313 1Avantis Medical Systems Inc Announces Key Leadership Appointments 7313 23SBio Inc to Present at the Morgan Stanley Global Healthcare Unplugged Conference 7311 1One Third of Schools Built in Air Pollution Danger Zones 25755 1One Third of Schools Built in Air Pollution Danger Zones 25755 2 Integrated Project Management Named to 26quot 3BInc 5000 26quot 3B for Second Year 3A One of the Top 100 Fastest Growing Companies in Chicago Are 7309 1 Integrated Project Management Named to 26quot 3BInc 5000 26quot 3B for Second Year 3A One of the Top 100 Fastest Growing Companies in Chicago Are 7309 2
...ire-FirstCall/ --,NeurogesX, Inc. announced today ...Phase 3 trial in postherpetic neuralgia (PHN).,Mis... at University,of Wisconsin in Madison and lead ac...to present the results of the study in a,June 8 po...on,Neuropathic Pain in Berlin, Germany. Dr. Backon...
...Society,s 11th,International Congress in Istanbul,...re-FirstCall/ -- New,information on the use of AZI...Parkinson,s disease (PD) was reported this week at...bul, Turkey.,Once-daily AZILECT was approved by th... and symptoms of PD, both as initial,monotherapy a...
Other Medicine Technology:NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG) 2NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG) 3NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG) 4International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 2International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 3International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 4International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 5International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 6
1 mm wide by 28 mm long sterling silver blade. Flat serrated handle with polished finish.
Double ended lasik spatula with flattened tip for lifting and smoothing the corneal flap. The sharp tip is useful to outline a previous flap in preparation for retreatment.
Serrated rake tip spatula with 20 gauge shaft. Black finish for reduced glare. Can be used with 20 gauge MVR blades.
Rounded tip spatula with 20 gauge shaft. Black finish for reduced glare.
Medicine Products: